This inventor holds 9 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Omeros Corporation, Cancer Research Technology Limited, Affitech Research as. Active years: 2014-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 99 
2 out of 268 
1 out of 11 Years Active: 2014-2023
Title: Herald Reiersen: Innovator in Anti-MASP-2 Antibodies
Introduction
Herald Reiersen is a prominent inventor based in Sofiemyr, Norway, known for his significant contributions to the field of biomedical innovations. With a total of nine patents to his name, Reiersen has focused extensively on advancing therapeutic approaches that address complex biological processes. His innovative work involves the development of compositions aimed at inhibiting adverse effects related to certain complement activation pathways.
Latest Patents
Among his latest inventions, Reiersen has developed two notable patents titled "Compositions for Inhibiting MASP-2 Dependent Complement Activation." These patents describe the use of anti-MASP-2 inhibitory antibodies and highlight the therapeutic potential of such compositions in mitigating the detrimental effects caused by MASP-2 dependent complement activation. This work underscores his commitment to improving treatment options for conditions influenced by these biological pathways.
Career Highlights
Throughout his career, Herald Reiersen has made impactful strides while working with esteemed organizations such as Omeros Corporation and Cancer Research Technology Limited. His involvement in these companies has enabled him to harness his expertise in biomedicine and contribute to innovative projects aimed at addressing critical health challenges.
Collaborations
In his professional journey, Reiersen has collaborated with notable figures in the industry, including Urs Beat Hagemann and Thomas Dudler. These collaborations have enriched his research experience and facilitated the progression of his innovative inventions, fostering an environment of shared knowledge and expertise.
Conclusion
Herald Reiersen's dedication to innovation and his pursuit of effective therapeutic solutions have established him as a respected inventor in the field. With his groundbreaking patents related to MASP-2 dependent complement activation, Reiersen continues to inspire advancements in biomedical research and therapeutic applications. His contributions signify the importance of creativity and collaboration in driving the future of medical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile